Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.64 3.30 4.80
(+10.3 pct) (-8.6 pct) (+9.4 pct)
Operating 562 mln 401 mln 500 mln
(+40.2 pct) (-10.8 pct) (+9.6 pct)
Recurring 578 mln 422 mln 500 mln
(+37.2 pct) (-5.1 pct) (+4.8 pct)
Net 394 mln 273 mln 350 mln
(+44.3 pct) (-10.1 pct) (+25.9 pct)
EPS 98.96 yen 65.35 yen 89.39 yen
Ann Div 12.50 yen 12.50 yen
-Q2 div NIL NIL
-Q4 div 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T